LATTANZIO, ROSSANO
 Distribuzione geografica
Continente #
NA - Nord America 2.541
EU - Europa 2.236
AS - Asia 1.171
OC - Oceania 11
SA - Sud America 7
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.973
Nazione #
US - Stati Uniti d'America 2.529
IT - Italia 587
SG - Singapore 451
IE - Irlanda 432
CN - Cina 371
SE - Svezia 288
UA - Ucraina 241
TR - Turchia 202
GB - Regno Unito 177
FR - Francia 162
DE - Germania 146
IN - India 81
FI - Finlandia 65
RU - Federazione Russa 48
VN - Vietnam 34
CZ - Repubblica Ceca 24
AT - Austria 21
BE - Belgio 17
AU - Australia 10
JP - Giappone 10
CA - Canada 9
BR - Brasile 7
PL - Polonia 7
HK - Hong Kong 6
MO - Macao, regione amministrativa speciale della Cina 4
CH - Svizzera 3
ES - Italia 3
NL - Olanda 3
PT - Portogallo 3
TH - Thailandia 3
CU - Cuba 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
GR - Grecia 2
IR - Iran 2
PH - Filippine 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
KR - Corea 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
SC - Seychelles 1
TW - Taiwan 1
Totale 5.973
Città #
Chandler 498
Dublin 423
Singapore 407
Jacksonville 327
Princeton 160
Ashburn 144
Santa Clara 130
Southend 124
Dearborn 112
Izmir 102
Chieti 97
Nanjing 96
Ann Arbor 78
Beijing 76
Altamura 73
Wilmington 73
Boardman 51
Cambridge 50
New York 40
Pescara 37
Collecorvino 36
Los Angeles 35
Dong Ket 34
Nanchang 31
Shenyang 26
Washington 26
Woodbridge 24
Hebei 21
Munich 21
Vienna 21
Milan 19
Brno 17
Rome 17
Jiaxing 16
Tianjin 16
Brussels 15
San Vito Chietino 15
Houston 14
Helsinki 13
Grevenbroich 12
London 12
Jinan 11
Catania 10
Kunming 10
Lappeenranta 10
Seattle 10
Bologna 8
Chicago 8
Norwalk 8
Kraków 7
Ascoli Piceno 6
Carrara 6
Changsha 6
Grafing 6
Hong Kong 6
Oklahoma City 6
Orange 6
Ottawa 6
Oxford 6
Romola 6
Shanghai 6
Edinburgh 5
Florence 5
Guangzhou 5
Hangzhou 5
Messina 5
Niigata 5
Ningbo 5
Pune 5
Sydney 5
Zhengzhou 5
Ancona 4
Carini 4
Frankfurt am Main 4
Horley 4
Lanzhou 4
Loma Linda 4
Macao 4
Mcallen 4
Olomouc 4
Ponte San Pietro 4
Taizhou 4
Basciano 3
Città Sant'Angelo 3
Fremont 3
Hefei 3
Issy-les-moulineaux 3
Kocaeli 3
Montesilvano 3
Moscow 3
Nonthaburi 3
Orsogna 3
Parma 3
Perth 3
Ripollet 3
Spoltore 3
Tokyo 3
Zurich 3
Atessa 2
Cattolica 2
Totale 3.833
Nome #
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 178
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer 166
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 147
Trop-2 is a determinant of breast cancer survival. 131
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 130
A unique four-hub protein cluster associates to glioblastoma progression 120
Trop-2 activates a dormant Na/K-ATPase/PKCa/CD9/ezrin signaling axis to override the basal growth program of cancer cells 111
Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice 106
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 103
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations 101
P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations 101
An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancer. 99
The Trop-2 signalling network in cancer growth 98
High expression of 90K (Mac-2 BP) is associated with poor survival in node-negative breast cancer patients not receiving adjuvant systemic therapies 97
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 97
Prognostic relevance of LGALS3BP in human colorectal carcinoma 97
Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants 94
Molecular expression profiling shows pseudohypoxia phenotype, vasculogenesis and mitochondrial dysfunction in head and neck paragangliomas 94
Molecular studies of pulmonary carcinoids 93
Vav1 down-modulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome 93
Trop-2 induces tumor growth through Akt and determines sensitivity to Akt inhibitors 92
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 90
Upregulation of Trop-2 quantitatively stimulates human cancer growth 89
NSC, SC and pleural screening of lung carcinoids for somatic mutations of MEN1 gene. 88
Pioneers in Pathology 87
Anomalous Fusion of Right Pulmonary Artery to Aortic Arch: Case Report of a Rare and Fatal Congenital Malformation in a Newborn and a Literature Review 87
Sunitinib malate (SU-11248) alone or in combination with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts. 85
Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody. 85
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 85
Trop-1 are conserved growth stimulatory molecules that mark early stages of tumor progression 85
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 84
Exosomes as pleiotropic players in pancreatic cancer 84
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading 83
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction 82
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 82
ABCC3 is a novel target for the treatment of pancreatic cancer 81
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 80
The splicing factor PTBP1 promotes expression of oncogenic splice variants and predicts poor prognosis in patients with non-muscle-invasive bladder cancer 79
Oxidative Stress Induces WNT Canonical/Non-Canonical Pathway Modulation in Colon Cancer Cells with APC or beta-Catenin Mutation 79
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 77
Molecular expression profiling shows overlapping pseudohypoxia phenotype and mitochondrial dysfunction in head and neck paragangliomas 77
Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids 74
LGALS3BP, A TUMOR-ASSOCIATED ANTIGEN, UPREGULATES VEGF IN HUMAN BREAST CANCER: POSSIBLE IMPLICATIONS IN ANGIOGENESIS 74
Oxidative Distress Induces Wnt/β-Catenin Pathway Modulation in Colorectal Cancer Cells: Perspectives on APC Retained Functions 74
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival 73
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals 72
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 72
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 72
Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice 72
Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease 71
The role of phospholipase Cγ1 in breast cancer and its clinical significance 71
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 71
[Tissue microarrays] 70
Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody 67
Intestinal tumour chemoprevention with the antioxidant lipoic acid stimulates the growth of breast cancer. 65
Phospholipase Cgamma1 is required for metastasis development and progression 65
Role of phospholipase C in cell invasion and metastasis 65
OXIDATIVE STRESS CAN DIFFERENTIALLY MODULATE WNT/β- CATENIN AND JNK SIGNALLING RELATIONSHIPS IN PRIMARY VERSUS METASTATIC CRC CELLS 62
Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer 60
mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/β-catenin 59
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process. 59
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 57
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 56
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion 55
Overexpression of activated phospholipase Cgamma1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy 54
Cyclin A2 maintains colon homeostasis and is a prognostic factor in CRC 51
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. 47
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer 45
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer 42
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis 39
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 38
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 38
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 38
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 37
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 35
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 34
Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice 34
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 33
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 31
The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium 30
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 28
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 26
Loss of primary cilia promotes inflammation and carcinogenesis 24
Soft tissue integration of different abutment surfaces: An experimental study with histological analysis 24
Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes 24
The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer 23
Differential Regulation of Wingless-Wnt/c-Jun N-Terminal Kinase Crosstalk via Oxidative Eustress in Primary and Metastatic Colorectal Cancer Cells 21
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 20
Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities 19
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks 19
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 17
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer 17
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 16
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 11
Totale 6.468
Categoria #
all - tutte 26.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020647 0 0 0 0 84 84 139 70 49 114 91 16
2020/2021512 69 8 77 27 63 83 18 10 43 48 11 55
2021/2022512 17 7 25 126 14 47 10 24 31 22 64 125
2022/20231.337 104 236 78 135 138 219 69 121 138 17 42 40
2023/2024908 52 28 67 38 52 288 175 42 25 31 12 98
2024/20251.042 89 439 375 88 51 0 0 0 0 0 0 0
Totale 6.468